Records containing: Vascular Anomalies

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-04-24
VATCH (Vascular Anomaly Analysis for Therapy Choice): A Phase II Study of Trametinib Treatment in Subjects With Ras/MAPK Pathway Driven Vascular Anomalies
CLINICAL_TRIALS study record update · 2026-04-22
VATCH (Vascular Anomaly Analysis for Therapy Choice): Phase II Study of Alpelisib Treatment in Subjects With TIE2/PIK3CA Pathway Driven Vascular Anomalies
CLINICAL_TRIALS study record update · 2026-02-19
A Modular Open Label, Signal Seeking, Phase II Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations (TARGET-VM)
CLINICAL_TRIALS study record update · 2026-01-14
Institutional Registries of Rare Diseases at Hospital Italiano de Buenos Aires (HIBA)
CLINICAL_TRIALS study record update · 2025-07-22
Safety and Efficacy of Trametinib for Complicated Vascular Anomalies: A Multicenter Prospective Study
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2025-01-31
Use of the Moving Shot Radiofrequency Ablation Technique for the Treatment of Vascular Anomalies
CLINICAL_TRIALS study record update · 2024-06-17
Safety and Efficacy Of Amber Peripheral Liquid Embolic System: a First-in-HumAn & PivotaL Study
CLINICAL_TRIALS study record update · 2021-11-10
A Phase II Clinical Study to Evaluate the Efficacy and Safety of Rapamycin in Complex Vascular Anomalies in Pediatric Patients
CLINICAL_TRIALS study record update · 2008-01-09
Phase I Dose Escalation Study to Evaluate the Safety and Preliminary Efficacy of Marimastat in Patients With Disabling Malformations and No Other Treatment Options